- Home
- HAS vs ITRM Comparison
HAS vs ITRM Comparison
Compare HAS & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAS
- ITRM
- Stock Information
- Founded
- HAS 1923
- ITRM 2015
- Country
- HAS United States
- ITRM Ireland
- Employees
- HAS N/A
- ITRM N/A
- Industry
- HAS Recreational Games/Products/Toys
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- HAS Consumer Discretionary
- ITRM Health Care
- Exchange
- HAS Nasdaq
- ITRM Nasdaq
- Market Cap
- HAS 8.6B
- ITRM 35.6M
- IPO Year
- HAS N/A
- ITRM 2018
- Fundamental
- Price
- HAS $62.16
- ITRM $1.03
- Analyst Decision
- HAS Strong Buy
- ITRM Strong Buy
- Analyst Count
- HAS 9
- ITRM 2
- Target Price
- HAS $79.56
- ITRM $7.00
- AVG Volume (30 Days)
- HAS 2.3M
- ITRM 536.8K
- Earning Date
- HAS 04-24-2025
- ITRM 05-13-2025
- Dividend Yield
- HAS 4.53%
- ITRM N/A
- EPS Growth
- HAS N/A
- ITRM N/A
- EPS
- HAS 3.03
- ITRM N/A
- Revenue
- HAS $4,265,300,000.00
- ITRM N/A
- Revenue This Year
- HAS $1.54
- ITRM N/A
- Revenue Next Year
- HAS $5.17
- ITRM $108.39
- P/E Ratio
- HAS $20.41
- ITRM N/A
- Revenue Growth
- HAS N/A
- ITRM N/A
- 52 Week Low
- HAS $49.00
- ITRM $0.81
- 52 Week High
- HAS $73.46
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- HAS 61.68
- ITRM 44.07
- Support Level
- HAS $60.33
- ITRM $0.88
- Resistance Level
- HAS $62.82
- ITRM $1.14
- Average True Range (ATR)
- HAS 1.88
- ITRM 0.10
- MACD
- HAS 0.63
- ITRM -0.01
- Stochastic Oscillator
- HAS 96.66
- ITRM 30.56
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.